Naritoshi Shirata

426 citations
11 papers · 332 indexed · h-index 10
Topics
Mast cells and histamine (4 papers)Renal Diseases and Glomerulopathies (3 papers)Estrogen and related hormone effects (2 papers)
Partner nations
JapanSwedenUnited States

In The Last Decade

Naritoshi Shirata

11 papers receiving 332 citations

Peers

Naritoshi Shirata
Comparison fields: 5 of 67
  • Molecular Biology 135
  • Immunology 114
  • Physiology 81
  • Pharmacology 55
  • Nephrology 43
Replace Ryo Hatano with:
Ryo Hatano Japan
Kelly M. England United States
Pradeep Bompada Sweden
Kirsten Scholz Germany
Nicole Weis Germany
Swarna Lekha Vijayaraj Australia
Alysia Kern Lovgren United States
Fei Qiao China
Ming‐Wei Chien Taiwan
Naritoshi Shirata relative to Ryo Hatano Japan Ryo Hatano's profile →
Citations per field
00.5×5.1×
Ryo Hatano · 1×
Citations per year

Countries citing papers authored by Naritoshi Shirata

Since Specialization
Citations

This map shows the geographic impact of Naritoshi Shirata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naritoshi Shirata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naritoshi Shirata more than expected).

Fields of papers citing papers by Naritoshi Shirata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naritoshi Shirata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naritoshi Shirata. The network helps show where Naritoshi Shirata may publish in the future.

Co-authorship network of co-authors of Naritoshi Shirata

This figure shows the co-authorship network connecting the top 25 collaborators of Naritoshi Shirata. A scholar is included among the top collaborators of Naritoshi Shirata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naritoshi Shirata. Naritoshi Shirata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 9
2 5
3 16
4 42
5 16
6 28
7 108
8 39
9 15
10 39
11 15

About Naritoshi Shirata

Naritoshi Shirata is a scholar working on Nephrology, Immunology and Immunology and Allergy, having authored 11 papers that have together received 332 indexed citations. Recurring topics across this work include Mast cells and histamine (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Immunology and Allergy (37 citations), Nephrology (43 citations) and Immunology (114 citations). Naritoshi Shirata has collaborated with scholars based in Japan, Sweden and United States. Frequent co-authors include Yukihiko Sugimoto, Tomoaki Inazumi, Kazushi Morimoto, Soken Tsuchiya, Eri Segi‐Nishida, Satoshi Tanaka, Makoto Murakami, Yoshitaka Taketomi, Kenji Kabashima and Shuh Narumiya. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026